NEO NeoGenomics, Inc.

NASDAQ
$19.33

NeoGenomics, Inc. (NEO) is expected to report earnings on November 2, 2026, after the market close. The consensus earnings estimate is a loss of $0.01 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +25.0% since its last earnings release on July 28, 2026.

NeoGenomics Beat Expectations, Raises Guidance
Tuesday, July 28, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 2
Monday · 4:05 PM ET
Earnings Whisper
-
vs ($0.01) (GAAP)
Rev est $205.42M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $17.18

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About NeoGenomics, Inc.

NeoGenomics Inc operates a network of cancer-related testing laboratories in Ft. Myers and Tampa, Florida; Irvine, California; and Nashville, and Tennessee.

Sector

Healthcare

Industry

Medical Labs & Research

Held By 4 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.